Analyst firms · Leerink Partners · DOCS
Leerink Partners DOCS price target and rating history
Doximity Inc. (DOCS) · Technology
Leerink Partners rates Doximity Inc. (DOCS) Outperform with a $90 price target, as of its latest action on Feb 7, 2025. It has published 4 rating actions on DOCS since July 2021, including 1 upgrade and 0 downgrades. Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.
- Current rating
- Outperform
- Price target
- $90
- Median target, all firms
- $27
- Actions on DOCS
- 4
Leerink Partners price target on DOCS
Every Leerink Partners rating on DOCS
- Feb 7, 2025
- Feb 26, 2024
- Nov 10, 2021
- Jul 19, 2021
How other firms rate DOCS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Underweight | $18 | Aug 10, 2026 |
| BofA Securities | Underperform | $20 | Jun 29, 2026 |
| Barclays | Equal Weight | $20 | May 15, 2026 |
| KeyBanc Capital Markets | Sector Weight | May 14, 2026 | |
| Robert W. Baird | Neutral | $18 | May 14, 2026 |
| BTIG | Neutral | May 14, 2026 | |
| Jefferies | Hold | $19 | May 14, 2026 |
| Truist Securities | Hold | $29 | Apr 20, 2026 |
| Evercore ISI | In-line | $25 | Apr 8, 2026 |
| Canaccord Genuity | Buy | $34 | Feb 9, 2026 |
| RBC Capital Markets | Outperform | $59 | Jan 9, 2026 |
| Morgan Stanley | Overweight | $65 | Dec 15, 2025 |
| Raymond James | Strong Buy | $65 | Nov 21, 2025 |
| BMO Capital Markets | Market Perform | $55 | Nov 13, 2025 |
Questions about Leerink Partners and DOCS
- What is Leerink Partners's price target for DOCS?
- Leerink Partners's latest stated price target for Doximity Inc. (DOCS) is $90, from its action on Feb 7, 2025.
- What is Leerink Partners's rating on DOCS?
- Leerink Partners rates DOCS Outperform, a bullish rating, as of Feb 7, 2025.
- When did Leerink Partners last change its view on DOCS?
- On Feb 7, 2025, Leerink Partners upgrades to Outperform from Market Perform, price target $60 to $90.
- How does Leerink Partners's DOCS target compare with other analysts?
- Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.
More DOCS rating histories
- Wells Fargo7
- BofA Securities6
- Barclays4
- KeyBanc Capital Markets3
- Robert W. Baird3
- BTIG3
- Jefferies3
- Truist Securities3
- Evercore ISI3
- Canaccord Genuity4
- Morgan Stanley8
- Raymond James5
- Goldman Sachs6
- Piper Sandler4
- Needham6
- J.P. Morgan4
- Guggenheim3
All Leerink Partners ratingsDOCS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.